CD4+ T cells can protect APC from CTL-mediated elimination

被引:35
|
作者
Mueller, Scott N.
Jones, Claerwen M.
Stock, Angus T.
Suter, Mark
Heath, William R.
Carbone, Francis R. [1 ]
机构
[1] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia
[2] Univ Zurich, Inst Virol, Zurich, Switzerland
[3] Walter & Eliza Hall Inst Med Res, Immunol Div, Parkville, Vic, Australia
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 12期
关键词
D O I
10.4049/jimmunol.176.12.7379
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Professional APC play a central role in generating antiviral CD8(+) CTL immunity. However, the fate of such APC following interaction with these same CTL remains poorly understood. We have shown previously that prolonged Ag presentation persists in the presence of a strong CTL response following HSV infection. In this study, we examined the mechanism of survival of APC in vivo when presenting an,immunodominant determinant from HSV. We show that transferred peptide-labeled dendritic cells were eliminated from draining lymph nodes in the presence of HSV-specific CTL. Maturation of dendritic cells with LPS or anti-CD40 before injection protected against CTL lysis in vivo. Furthermore, endogenous APC could be eliminated from draining lymph nodes early after HSV infection by adoptive transfer of HSV-specific CTL, yet the cotransfer of significant virus-specific CD4(+) T cell help promoted prolonged Ag presentation. This suggests that Th cells may assist in prolonging class I-restricted Ag presentation, potentially enhancing CTL recruitment and allowing more efficient T cell priming.
引用
收藏
页码:7379 / 7384
页数:6
相关论文
共 50 条
  • [41] Human peripheral CD4+ Vδ1+ γδT cells can develop into αβT cells
    Ziegler, Hendrik
    Welker, Christian
    Sterk, Marco
    Hearer, Jan
    Rammensee, Hans-Georg
    Handgretinger, Rupert
    Schilbach, Karin
    FRONTIERS IN IMMUNOLOGY, 2014, 5 : 1 - 23
  • [42] Small Numbers of CD4+ T Cells Can Induce Development of Lymphedema
    Ly, Catherine L.
    Cuzzone, Daniel A.
    Kataru, Raghu P.
    Mehrara, Babak J.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2019, 143 (03) : 518E - 526E
  • [43] Naive CD4+ T cells can be sensitized with IL-7
    Vakkila, J
    Äystö, S
    Saarinen-Pihkala, UM
    Sarioloa, H
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 54 (05) : 501 - 505
  • [44] Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
    Soudabeh Rad Pour
    Hiromasa Morikawa
    Narsis A. Kiani
    Muyi Yang
    Alireza Azimi
    Gowhar Shafi
    Mingmei Shang
    Roland Baumgartner
    Daniel F. J. Ketelhuth
    Muhammad Anas Kamleh
    Craig E. Wheelock
    Andreas Lundqvist
    Johan Hansson
    Jesper Tegnér
    Scientific Reports, 9
  • [45] Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells
    Dieckmann, D
    Plöttner, H
    Dotterweich, S
    Schuler, G
    IMMUNOLOGY, 2005, 115 (03) : 305 - 314
  • [46] PEPTIDE-MEDIATED ANERGY IN HUMAN CD4+ T-CELLS
    HEWITT, CRA
    LAMB, JR
    RESEARCH IN IMMUNOLOGY, 1992, 143 (03): : 294 - 296
  • [47] γδ T cells present antigen to CD4+ αβ T cells
    Collins, RA
    Werling, D
    Duggan, SE
    Bland, AP
    Parsons, KR
    Howard, CJ
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (06) : 707 - 714
  • [48] Rho GTPase-mediated pathways in mature CD4+ T cells
    Pernis, Alessandra B.
    AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 199 - 203
  • [49] Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms
    McKinstry, K. Kai
    Strutt, Tara M.
    Kuang, Yi
    Brown, Deborah M.
    Sell, Stewert
    Dutton, Richard W.
    Swain, Susan L.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (08): : 2847 - 2856
  • [50] CD8+lymphocyte mediated suppression of HIV expression in CD4+ T cells
    Franchitti, Lavinia
    Sharma, Ashish Arunkumar
    Yoon, Jack
    White, Erick
    Zhang, Zhan
    Wang, Hong
    Statzu, Maura
    Willemse, Abigail E.
    Bateganya, Lisa
    Silvestri, Guido
    Kulpa, Deanna
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 104 - 104